Reuters - Gleevec, a once-a-day pill that has
helped boost the survival rate for some leukemia patients,
lowers the risk that a rare stomach cancer will come back by 70
percent, U.S. researchers reported on Thursday.
Source: http://rss.news.yahoo.com
No comments:
Post a Comment